2018
DOI: 10.1016/j.scib.2017.12.015
|View full text |Cite
|
Sign up to set email alerts
|

Perylenediimide chromophore as an efficient photothermal agent for cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
23
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 50 publications
(24 citation statements)
references
References 41 publications
1
23
0
Order By: Relevance
“…[2][3] Recently,n anoscale drug carriers have been reported as an effective methodt oc ircumvent MDR and they offer ar emarkable intracellulard rug delivery mechanism to improvea nticancer efficacy. [4][5][6][7][8][9][10] Reduced graphene-based drug-delivery systems have attracted the most attention because of their unique physical, electrical and chemicalp roperties, andt hey have been widely used as biomedical treatments, particularly for use in photothermal therapy( PTT) and cell imaging. [11][12][13][14][15][16][17][18][19][20][21][22] PTT is one of the mostp rominentm ethods for the application of rGO-based nanodrug systems.…”
Section: Introductionmentioning
confidence: 99%
“…[2][3] Recently,n anoscale drug carriers have been reported as an effective methodt oc ircumvent MDR and they offer ar emarkable intracellulard rug delivery mechanism to improvea nticancer efficacy. [4][5][6][7][8][9][10] Reduced graphene-based drug-delivery systems have attracted the most attention because of their unique physical, electrical and chemicalp roperties, andt hey have been widely used as biomedical treatments, particularly for use in photothermal therapy( PTT) and cell imaging. [11][12][13][14][15][16][17][18][19][20][21][22] PTT is one of the mostp rominentm ethods for the application of rGO-based nanodrug systems.…”
Section: Introductionmentioning
confidence: 99%
“…Based on these results,t he in vitro therapeutic effect of PTN was further evaluated by the Cell Counting Kit-8 assay. [21] In the dark, ICy5 exhibits low dark toxicity in both cancer cells and normal cells ( Figure 3D;S upporting Information, Figure S34). Also,P TN shows ac omparable cell toxicity to that of free CPT (Supporting Information, Figure S35).…”
Section: Angewandte Chemiementioning
confidence: 97%
“…Compared to the traditional chemotherapy, nano-based delivery systems make it accessible to co-load chemotherapeutic compounds and chemosensitizing agents, including transporter protein inhibitors or gene-silencing agents, into one nanocarrier [23][24][25][26][27][28][29][30]. With continued elaborate engineering, through chemical modification or physical coating, such nano delivery systems can be tailored to serve a wealth of functions, such as active tumor targeting, environmentally-responsive drug release, and image-guided cancer theranostics [31][32][33]. Consequently, it is available to realize enhanced specificity to tumor sites, improved therapeutic index of MDR cancer, as well as decreased toxicity.…”
Section: Introductionmentioning
confidence: 99%